Challenges and strategies of medication adherence in Parkinson's disease: A qualitative study

Geriatric Nursing

Volumn 36, Issue 3, 2015, Pages 192-196

  Shin, Ju Young ^a   Habermann, Barbara ^a   Pretzer Aboff, Ingrid ^a  

^a UNIVERSITY OF DELAWARE   (United States)

Author keywords

Adherence; Challenges and strategies; Medication; Parkinson's disease

Indexed keywords

ANTIPARKINSON AGENT;

ADVERSE DRUG REACTION; AGED; ECONOMICS; FEMALE; HUMAN; INDEPENDENT LIVING; MALE; MEDICATION COMPLIANCE; MEMORY; MIDDLE AGED; PARKINSON DISEASE; PSYCHOLOGY; QUALITATIVE RESEARCH; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMANS; INDEPENDENT LIVING; MALE; MEDICATION ADHERENCE; MEMORY; MIDDLE AGED; PARKINSON DISEASE; QUALITATIVE RESEARCH;

EID: 84930088549     PISSN: 01974572     EISSN: 15283984     Source Type: Journal    
DOI: 10.1016/j.gerinurse.2015.01.003     Document Type: Article

References (26)

1. de Lau L.M.L., Breteler M.M.B. Epidemiology of Parkinson's disease. Lancet Neurol 2006, 5:525-535.
2. Huse D., Schulman K., Orsini L., et al. Burden of illness in Parkinson's disease. Mov Disord 2005, 20:1449-1454.
3. McCance K.L., Huether S.E. Pathophysiology. The Biologic Basis for Disease in Adults and Children 2010, Mosby, St. Louis, MO. 6th ed.
4. Pavon J.M., Whitson H.E., Okun M.S. Parkinson's disease in women: a call for improved clinical studies and for comparative effectiveness research. Maturitas 2010, 65:352-358.
5. Grosset D., Antonini A., Canesi M., et al. Adherence to antiparkinson medication in a multicenter European study. Mov Disord 2009, 24:826-832.
6. Kulkarni A.S., Balkrishnan R., Anderson R.T., et al. Medication adherence and associated outcomes in medicare health maintenance organization-enrolled older adults with Parkinson's disease. Mov Disord 2008, 23:359-365.
7. Davis K.L., Edin H.M., Allen J.K. Prevalence and cost of medication nonadherence in Parkinson's disease: evidence from administrative claims data. Mov Disord 2010, 25:474-480.
8. Richy F.F., Pietri G., Moran K.A., et al. Compliance with pharmacotherapy anddirect healthcare costs in patients with Parkinson's disease: a retrospective claims database analysis. Appl Health Econ Health Policy 2013, 11:395-406.
9. Tarrants M.L., Denarie M.F., Castelli-Haley J., et al. Drug therapies for Parkinson's disease: a database analysis of patient compliance and persistence. Am J Geriatr Pharmacother 2010, 8:374-383.
10. Wei Y., Palumbo F.B., Simoni-Wastila L., et al. Antiparkinson drug adherence and its association with health care utilization and economic outcomes in a Medicare part D population. Value Health 2014, 17:196-204.
11. Grosset K.A., Bone I., Grosset D.G. Suboptimal medication adherence in Parkinson's disease. Mov Disord 2005, 20:1502-1507.
12. Leopold N.A., Polansky M., Hurka M. Drug adherence in Parkinson's disease. Mov Disord 2004, 19:513-517.
13. Gould E., Mitty E. Medication adherence is a partnership, medication compliance is not. Geriatr Nurs 2010, 31:290-298.
14. Daley D.J., Deane K.H.O., Gray R.J., et al. Adherence therapy improved medication adherence and quality of life in people with Parkinson's disease: a randomized controlled trial. Int J Clin Pract 2014, 1-9.
15. Drey N., Mckeown E., Kelly D., et al. Adherence to antiparkinsonian medication: an in-depth qualitative study. Int J Nurs Stud 2012, 49:863-871.
16. Carter L. The role of specialist nurses in managing Parkinson's disease. Prim Health Care 2006, 16:20-22.
17. Sandelowski M. The problem of rigour in qualitative research. ANS Adv Nurs Sci 1986, 8:27-37.
18. Elo S., Kyngäs H. The qualitative content analysis process. JAdv Nurs 2008, 62:107-115.
19. Vaismoradi M., Turunen H., Bondas T. Content analysis and thematic analysis: implications for conducting a qualitative descriptive study. Nurs Health Sci 2013, 15:398-405.
20. Morse J.M., Field P.A. Qualitative Research Methods for Health Professionals 1995, Sage, Thousand Oaks, CA. 2nd ed.
21. Bainbridge J.L., Ruscin J.M. Challenges of treatment adherence in older patients with Parkinson's disease. Drugs Aging 2009, 26:145-155.
22. Brown M.T., Bussell J.K. Medication adherence: WHO cares?. Mayo Clin Proc 2011, 86:304-314.
23. Wheeler K.J., Roberts M.E., Neiheisel M.B. Medication adherence part two: predictorsof nonadherence and adherence. JAm Assoc Nurse Pract 2014, 26:225-232.
24. Hughes C.M. Medication non-adherence in the elderly: how big is the problem?. Drugs Aging 2004, 21:793-811.
25. Drug Coverage (Part D): Costs in the Coverage Gap 2014, Centers for Medicare & Medicaid Services, Retrieved from the Medicare website:. http://www.medicare.gov/part-d/costs/coverage-gap/part-d-coverage-gap.html.
26. Cohen R.A., Kirzinger W.K., Gindi R.M. Strategies Used by Adults to Reduce Their Prescription Drug Costs 2013, NCHS Data Brief, 119, National Center for Health Statistics, Hyattsville, MD.